ImportRefusal LogoImportRefusal

Skynet Interntional

⚠️ High Risk

FEI: 3003942417 • Manila • PHILIPPINES

FEI

FEI Number

3003942417

📍

Location

Manila

🇵🇭
🏢

Address

3333 New Panaderos St, , Manila, , Philippines

High Risk

FDA Import Risk Assessment

53.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

9
Total Refusals
4
Unique Violations
6/2/2005
Latest Refusal
7/23/2004
Earliest Refusal

Score Breakdown

Violation Severity
82.5×40%
Refusal Volume
37.0×30%
Recency
0.0×20%
Frequency
90.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

Refusal History

DateProductViolationsDivision
6/2/2005
66MDA03ALPRAZOLAM (TRANQUILIZER)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
61PDA31GLIMEPIRIDE (ANTI-DIABETIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
62ODA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
61JDA99ANTI-CHOLESTEREMIC, N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
61LDA38CLOPIDOGREL BISULFATE (ANTI-COAGULANT)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
66SDA48ISOSORBIDE MONONITRATE (VASODILATOR)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/21/2005
66RDA99VASOCONSTRICTOR N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/29/2004
60LAY99ANALGESIC, N.E.C.
118NOT LISTED
483DRUG NAME
75UNAPPROVED
San Francisco District Office (SAN-DO)
7/23/2004
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
27DRUG GMPS
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Skynet Interntional's FDA import refusal history?

Skynet Interntional (FEI: 3003942417) has 9 FDA import refusal record(s) in our database, spanning from 7/23/2004 to 6/2/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Skynet Interntional's FEI number is 3003942417.

What types of violations has Skynet Interntional received?

Skynet Interntional has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Skynet Interntional come from?

All FDA import refusal data for Skynet Interntional is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.